SYNTHESIS, CHARACTERIZATION OF A CHITOSAN SCHIFF BASE AND COPPER COMPLEXES USED AS A MODIFIED ELECTRODE. A new material formed by Shiff base (chitosan and ortho-vanillin) and copper were synthesized and characterized by UV-visible, infrared spectroscopies, thermal analysis, elemental analysis, electron microscopy, 1H NMR spectra and electrochemical techniques. In this study, it was possible to identify the formation of Schiff’s base (BS), with a degree of substitution of 42.5% by NMR. The electron microscopy study indicates an amorphous character for BS. The material was used to build an electrode, which proved to be sensitive to the addition of nitrite, making it possible to quantify it. The values obtained for detection limit and limit of quantification of the electrode formed BS-Cu were 0.062 µmol L-1 and 0.21 µmol L-1, respectively.
Aim: To evaluate the effect of a new Fe-cyclam complex on pathogenic bacterial species, including multidrug-resistant clinical specimens. Materials & methods: The complex [Fe(cyclam)ox]PF6 (D2) was tested in cytotoxicity and MIC tests. Clinical and reference strains of Gram-negative and Gram-positive bacteria were used. Considering Staphylococcus aureus strains, the profile of antimicrobial susceptibility and time–kill kinetics for D2 was performed. An in silico analysis for D2 was also performed. Results: D2 showed broad bacterial activity, mainly against specimens of Cutibacterium acnes, S. aureus, Pseudomonas aeruginosa and Acinetobacter baumannii. Low cytotoxicity in human cells was demonstrated. Conclusion: The tested compound proved to be a promising agent against resistant bacterial infections.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.